Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 8
Author(s): M. Haber
Affiliation:
Export Options
About this article
Cite this article as:
Haber M. , Meet Our Editorial Board Member, Current Cancer Drug Targets 2018; 18 (8) . https://dx.doi.org/10.2174/156800961808180829102109
DOI https://dx.doi.org/10.2174/156800961808180829102109 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
30
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Degludec: A Novel Basal Insulin
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review
Current Medicinal Chemistry New Therapies for Chronic Lymphocytic Leukemia
Current Cancer Therapy Reviews MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights
MicroRNA Regulation of CREB Functions by Phosphorylation and Sumoylation in Nervous and Visual Systems
Current Molecular Medicine Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione
Anti-Cancer Agents in Medicinal Chemistry Preface
Pharmaceutical Nanotechnology Clinical Significance of Umami Taste and Umami-Related Gene Expression Analysis for the Objective Assessment of Umami Taste Loss
Current Pharmaceutical Design Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology
Current Pharmaceutical Design A New Nonlinear Mixture Response Surface Paradigm for the Study of Synergism: A Three Drug Example
Current Drug Metabolism The Therapeutic Target Hsp90 and Cancer Hallmarks
Current Pharmaceutical Design A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Engineered Liposomes for Drug Delivery and Biomedical Imaging
Recent Patents on Nanomedicine Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
Current Pharmaceutical Design Is Type D Personality Here to Stay? Emerging Evidence Across Cardiovascular Disease Patient Groups
Current Cardiology Reviews Cetuximab Inhibits Gastric Cancer Growth in vivo, Independent of KRAS Status
Current Cancer Drug Targets Chemotherapy for Laryngeal Cancer - An Apoptotic Approach
Current Drug Targets The Mechanisms Responsible for Garlic - Drug Interactions and their In Vivo Relevance
Current Drug Metabolism Cancer-Associated Carbonic Anhydrases and Their Inhibition
Current Pharmaceutical Design Meet Our Editor-in-Chief
Clinical Cancer Drugs